Squarepoint Ops LLC Clovis Oncology, Inc. Transaction History

Squarepoint Ops LLC

$62.8 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$1.05 - $2.85 $24,840 - $67,425	-23,658 Reduced 58.62%	16,700 $20,000
Q2 2022 Aug 15, 2022	SELL	$0.63 - $2.96 $135,691 - $637,533	-215,383 Reduced 84.22%	40,358 $73,000
Q1 2022 May 16, 2022	BUY	$1.43 - $3.14 $276,340 - $606,789	193,245 Added 309.21%	255,741 $517,000
Q4 2021 Feb 14, 2022	SELL	$2.7 - $4.76 $239,206 - $421,712	-88,595 Reduced 58.64%	62,496 $169,000
Q3 2021 Nov 15, 2021	BUY	$4.06 - $5.8 $24,449 - $34,927	6,022 Added 4.15%	151,091 $674,000
Q2 2021 Aug 16, 2021	BUY	$5.02 - $7.05 $372,222 - $522,743	74,148 Added 104.55%	145,069 $841,000
Q1 2021 May 17, 2021	SELL	$4.81 - $10.34 $201,712 - $433,618	-41,936 Reduced 37.16%	70,921 $498,000
Q4 2020 Feb 16, 2021	BUY	$4.13 - $6.41 $466,099 - $723,413	112,857 New	112,857 $542,000
Q2 2020 Aug 14, 2020	SELL	$5.69 - $9.69 $249,836 - $425,468	-43,908 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$3.77 - $11.0 $119,987 - $350,097	-31,827 Reduced 42.02%	43,908 $279,000
Q4 2019 Feb 14, 2020	SELL	$3.0 - $16.43 $651,327 - $3.57 Million	-217,109 Reduced 74.14%	75,735 $790,000
Q3 2019 Nov 14, 2019	BUY	$3.93 - $15.35 $989,892 - $3.87 Million	251,881 Added 614.9%	292,844 $1.15 Million
Q2 2019 Aug 14, 2019	BUY	$12.81 - $25.67 $128,663 - $257,829	10,044 Added 32.48%	40,963 $609,000
Q1 2019 May 15, 2019	SELL	$17.66 - $30.28 $848,845 - $1.46 Million	-48,066 Reduced 60.85%	30,919 $767,000
Q4 2018 Feb 14, 2019	BUY	$11.63 - $32.67 $838,709 - $2.36 Million	72,116 Added 1049.88%	78,985 $1.42 Million
Q3 2018 Nov 14, 2018	SELL	$29.37 - $49.48 $982,925 - $1.66 Million	-33,467 Reduced 82.97%	6,869 $202,000
Q2 2018 Aug 14, 2018	BUY	$42.06 - $62.4 $1.44 Million - $2.13 Million	34,136 Added 550.58%	40,336 $1.83 Million
Q1 2018 May 15, 2018	SELL	$50.12 - $67.72 $215,165 - $290,721	-4,293 Reduced 40.91%	6,200 $327,000
Q4 2017 Feb 14, 2018	BUY	$57.69 - $84.58 $605,341 - $887,497	10,493	10,493 $714,000

Others Institutions Holding CLVS

# of Institutions

Shares Held

166

Call Options Held

Put Options Held

Exane Derivatives

166
Shares

$14
0.0% of portfolio

View Full List

About Clovis Oncology, Inc.

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

More about CLVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Account